ErbB2 and a6 integrin have been implicated in malignancy of breast cancer cells. Here we have determined the influence of a6b1 integrin on erbB2 signaling in anchorage-independent growth, using MDA-MB435 breast cancer cells. Firstly, we transfected the cells with erbB2 cDNA, and isolated cells with high or low levels of a6b1 integrin by cell sorting (a6H-ErbB and a6L-ErbB). We found that an erbB ligand, heregulin b1, enhanced growth activity of a6L-ErbB cells, but not a6H-ErbB cells. Secondly, we established cells expressing a b4 integrin deletion mutant (b4-Dcyt), which selectively inhibited a6b1 integrin expression and adhesion to laminin-1. Again, heregulin b1 enhanced the growth of erbB2 cDNA-transfected b4-Dcyt cells, but not mock cells. Western blot analysis revealed that heregulin b1 stimulated phosphorylation of Akt and its downstream molecules, GSK3b and p70S6kinase, and that the extent of phosphorylation was greater in ErbB2/b4-Dcyt cells than ErbB2/mock cells. Furthermore, we found that the erbB2 cytoplasmic domain was truncated in ErbB2/mock cells, which was independent of ligand stimulation and adhesion, and was suppressed by proteasome inhibitors. These results suggest that a6b1 integrin inhibits erbB2 signals by inducing proteasome-dependent proteolytic cleavage of the erbB2 cytoplasmic domain, and may thereby contribute to the regulation of tumor growth.